STOCK TITAN

Humana (NYSE: HUM) chief medical officer reports 0 shares

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

HUMANA INC (HUM) reported the initial equity holdings of executive Shantanu Nundy, who serves as Chief Medical Officer. The report lists one line item for Humana Common with 0 shares beneficially owned following the reported position, indicating no direct holdings of Humana common stock at that time.

Positive

  • None.

Negative

  • None.
Insider Nundy Shantanu
Role Chief Medical Officer
Type Security Shares Price Value
holding Humana Common -- -- --
Holdings After Transaction: Humana Common — 0 shares (Direct)
Shares beneficially owned following report 0 Humana Common shares Reported for Shantanu Nundy as Chief Medical Officer
Holding entries reported 1 holding entry Number of reported entries for Humana Common
Humana Common financial
"security_title: "Humana Common""
Chief Medical Officer other
"officer_title": "Chief Medical Officer""
A chief medical officer is a senior executive responsible for overseeing the health and medical strategies within an organization, often in the healthcare or pharmaceutical sectors. They play a key role in guiding decisions related to medical research, product safety, and healthcare policies, which can impact a company's reputation and success. For investors, understanding the chief medical officer's role helps gauge how well a company manages medical risks and advances its healthcare goals.
beneficially owned financial
"total_shares_following_transaction": "0.0000""
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

What does the HUM Form 3 report for Chief Medical Officer Shantanu Nundy?

It reports Shantanu Nundy’s initial beneficial ownership in Humana Common as 0 shares following the reported position, indicating no direct common stock holdings at that time.

How many HUM shares does Shantanu Nundy directly own according to this Form 3?

According to the report, Shantanu Nundy directly owns 0 shares of Humana Common following the reported position.

What is Shantanu Nundy’s role at HUMANA INC (HUM)?

Shantanu Nundy is reported as an officer of HUMANA INC with the title Chief Medical Officer.

Does the HUM Form 3 show any recent purchases or sales by Shantanu Nundy?

No. The report contains a single holding entry for Humana Common and shows 0 shares beneficially owned, with no buy or sell transactions indicated.

What type of security is listed for Shantanu Nundy in the HUM Form 3?

The report lists one security type: Humana Common, with a reported beneficial ownership of 0 shares following the position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Nundy Shantanu

(Last)(First)(Middle)
HUMANA INC.
101 E. MAIN STREET

(Street)
LOUISVILLE KENTUCKY 40202

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
08/31/2026
3. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Medical Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Humana Common0D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Shantanu Nundy08/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)